Week Ending November 15, 2021

Hope Shared for Patients With Cancer Is Hope Multiplied
“A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.”

Guiding the Way for Patients With Lung Cancer: ‘He Is my Hero’
“I was diagnosed with lung cancer in 2011. It didn’t look good. Dr. Abraham Chachoua kept me alive long enough to get me into the 2015 drug trial for Opdivo (nivolumab) at Memorial Sloan Kettering Cancer Center. I had such bad side effects that I didn’t finish the trial. But it worked.”

Yale doctor: Getting screened for lung cancer could save your life, but few do
“Many more smokers and ex-smokers would have a better chance at avoiding a fatal case of lung cancer if they got their annual screening, but few do, according to the chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital.”

The First of Many Advancements to Come for a Lung Cancer Mutation
“Recent drug approvals by the Food and Drug Administration (FDA) are giving patients with non-small cell lung cancer (NSCLC) and EGFR exon 20 insertion mutations the first two treatments that specifically target those mutations.”

MSK Researchers Are Learning Why Some Patients Develop Resistance to ‘Landmark’ Lung Cancer Drug
“The recent approval of sotorasib (LumakrasTM) was considered a watershed event, because the drug obstructs a cancer-causing protein that for decades scientists thought was “undruggable.” Sotorasib was approved by the US Food and Drug Administration (FDA) in May 2021 for the treatment of people with advanced non-small cell lung cancers caused by a gene mutation called KRAS G12C.”

SCLC: Treatment Advancing 1 Small, but Quickening, Step at a Time
“Lung cancer is the second most diagnosed cancer after breast cancer. It is subdivided into small cell (SCLC) and non–small cell lung (NSCLC) cancers with NSCLC occurring approximately 85% of the time and SCLC the remainder.”

New study finds barriers still exist with lung cancer screening access
“A new study finds that the recent changes to lung cancer screening guidelines may paradoxically increase health disparities rather than reduce them, given a gap of insurance coverage for some people. The study, published in JAMA Network Open in October, was led by Gerard Silvestri, M.D., a pulmonologist and MUSC Hollings Cancer Center researcher.”

Nonsmoker, 38, diagnosed with stage 4 lung cancer shares story: ‘I had no idea’
“The private investigator never realized that nonsmokers were diagnosed with lung cancer and wants to raise awareness to help others.”

Healthcare professionals “walk out” on lung cancer to spread awareness
“Misty Lewis was among many other East Texans “walking out” on lung cancer Thursday morning.”


VIDEO: ‘Fascinating’ discussion on new lung cancer screening eligibility criteria at CHEST
“In this video, Julie A. Barta, MD, pulmonologist and assistant professor at Thomas Jefferson University Hospitals, talks with Healio about a discussion on controversial new lung cancer screening guidance presented at CHEST”.

Lung cancer survivors detail battles amid advances in screening and treatment
“CLEVELAND (WJW) – November marks National Lung Cancer Awareness Month, and while lung cancer remains the deadliest form of cancer, there have been promising new advances in screening and treatment.”